Literature DB >> 24924731

[Large vessel vasculitis].

S Weigand1, M Fleck.   

Abstract

Giant cell arteritis (GCA) and Takayasu arteritis (TA) are the two diseases characterized as large vessel vasculitis (LVV) and are autoimmune diseases with granulomatous inflammation that affect medium and large sized arteries. These diseases are accompanied by symptoms of systemic inflammatory reactions typically including fatigue, weight loss and low grade fever as well as elevation of the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels. More specific symptoms include headache and visual symptoms for GCA and arm or leg claudication, renal hypertension and angina pectoris for TA. Imaging studies to demonstrate inflammatory vascular wall lesions and biopsy of the temporal artery for GCA are the most relevant diagnostic procedures. Treatment relies mainly on glucocorticoids. Methotrexate seems to have a moderate glucocorticoid-sparing effect but evidence for other immunosuppressants, including azathioprine, tocilizumab and cyclophosphamide is limited. Revascularization methods might also be required in TA.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24924731     DOI: 10.1007/s00393-014-1416-x

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  34 in total

1.  Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study.

Authors:  G G Hunder; S G Sheps; G L Allen; J W Joyce
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

2.  Systemic manifestations of Takayasu arteritis: the expanding spectrum.

Authors:  B K Sharma; S Jain; S Sagar
Journal:  Int J Cardiol       Date:  1996-08       Impact factor: 4.164

3.  Mortality in patients with biopsy-proven giant cell arteritis: a south australian population-based study.

Authors:  Jem Ninan; Anh-Minh Nguyen; Antonia Cole; Maureen Rischmueller; Thomas Dodd; Peter Roberts-Thomson; Catherine L Hill
Journal:  J Rheumatol       Date:  2011-08-15       Impact factor: 4.666

4.  Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica.

Authors:  S Unizony; L Arias-Urdaneta; E Miloslavsky; S Arvikar; A Khosroshahi; B Keroack; J R Stone; J H Stone
Journal:  Arthritis Care Res (Hoboken)       Date:  2012-11       Impact factor: 4.794

5.  Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial.

Authors:  Gary S Hoffman; Maria C Cid; Karen E Rendt-Zagar; Peter A Merkel; Cornelia M Weyand; John H Stone; Carlo Salvarani; Weichun Xu; Sudha Visvanathan; Mahboob U Rahman
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

6.  Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.

Authors:  Reva C Lawrence; David T Felson; Charles G Helmick; Lesley M Arnold; Hyon Choi; Richard A Deyo; Sherine Gabriel; Rosemarie Hirsch; Marc C Hochberg; Gene G Hunder; Joanne M Jordan; Jeffrey N Katz; Hilal Maradit Kremers; Frederick Wolfe
Journal:  Arthritis Rheum       Date:  2008-01

Review 7.  Takayasu's truncoarteritis. Pulseless disease or aortitis syndrome.

Authors:  T Nasu
Journal:  Acta Pathol Jpn       Date:  1982

Review 8.  Giant cell arteritis.

Authors:  S S L Chew; N M Kerr; H V Danesh-Meyer
Journal:  J Clin Neurosci       Date:  2009-07-07       Impact factor: 1.961

Review 9.  Recent advances in the medical management of Takayasu arteritis: an update on use of biologic therapies.

Authors:  Alison Clifford; Gary S Hoffman
Journal:  Curr Opin Rheumatol       Date:  2014-01       Impact factor: 5.006

10.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.